🇺🇸 Cerianna in United States

FDA authorised Cerianna on 20 May 2020

Marketing authorisations

FDA — authorised 20 May 2020

  • Application: NDA212155
  • Marketing authorisation holder: GE HEALTHCARE
  • Local brand name: CERIANNA
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA

  • Status: approved

Cerianna in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Cerianna approved in United States?

Yes. FDA authorised it on 20 May 2020; FDA has authorised it.

Who is the marketing authorisation holder for Cerianna in United States?

GE HEALTHCARE holds the US marketing authorisation.